In a larger study [22], in which genomic real-time PCR was used to measure MYCN copy number in a more heterogenous group of tumours from patients treated under various protocols (including immediate nephrectomy), we confirmed that MYCN gain is a common event, but found no particular subtype association. This evidence concerns the gene MYCN and neoplasm.